TrialJournal of the neurological sciences2013

A randomized, controlled, delayed start trial of GM1 ganglioside in treated Parkinson's disease patients.

Jay S Schneider et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.